Protara Therapeutics, Inc. - Common Stock (TARA)

Historical Holders from Q2 2020 to Q4 2024

Symbol
TARA on Nasdaq
CUSIP
74365U107
Type / Class
Equity / Common Stock
Shares outstanding
36.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
29.7M
Holdings value
$157M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
58
Number of buys
40
Number of sells
-15
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Protara Therapeutics, Inc. - Common Stock (TARA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 10.3% +71.7% $17.2M -$7.52M 3.79M -30.5% JANUS HENDERSON GROUP PLC Feb 28, 2025
RA CAPITAL MANAGEMENT, L.P. 9.9% $15.5M 3.43M RA Capital Management, L.P. Dec 31, 2024
Adage Capital Management, L.P. 6.56% $10.2M 2.25M Adage Capital Management, L.P. Dec 31, 2024
Opaleye Management Inc. 5.32% $8.27M 1.83M Opaleye Management, Inc. Dec 31, 2024
CITADEL ADVISORS LLC 4.7% $7.37M 1.63M Kenneth Griffin Dec 31, 2024
Woodline Partners LP 3.9% $6.03M 1.33M Woodline Partners LP Dec 31, 2024

Institutional Holders of Protara Therapeutics, Inc. - Common Stock (TARA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 29.7M $157M +$91.8M $5.28 58
2024 Q3 10.4M $19.1M +$384K $1.83 33
2024 Q2 10.4M $22.2M +$12M $2.08 39
2024 Q1 4.57M $18.3M +$911K $4.01 35
2023 Q4 4.36M $8.17M -$1.26M $1.88 30
2023 Q3 5.12M $8.55M -$31.8K $1.67 31
2023 Q2 5.14M $12.3M -$1.13M $2.39 28
2023 Q1 5.5M $16.9M +$77.6K $3.13 28
2022 Q4 5.48M $14.7M -$482K $2.68 29
2022 Q3 5.66M $16.7M -$785K $2.96 25
2022 Q2 5.93M $18.4M -$2.06M $2.93 31
2022 Q1 6.5M $33.2M -$1.96M $5.11 33
2021 Q4 6.87M $46.4M +$3.8M $6.75 35
2021 Q3 6.31M $43.7M -$8.44M $6.92 36
2021 Q2 7.06M $68.8M -$22.6M $9.74 36
2021 Q1 8.53M $134M -$11.6M $15.74 50
2020 Q4 8.78M $212M -$5.8M $24.21 49
2020 Q3 9.28M $156M +$91.8M $16.83 44
2020 Q2 3.7M $108M +$108M $29.32 31